FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

M C W Creemers

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Genotype

Co-author Network

Publications

TOP 3
Laura T C van Hulst; M C W Creemers; Jaap Fransen; Linda C Li; Richard Grol; Marlies E J L Hulscher; Piet L C M van Riel
How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led intervention.
Sabine J M de Brouwer; Floris W Kraaimaat; Fred C G J Sweep; M C W Creemers; Timothy R D J Radstake; Antoinette I M van Laarhoven; Piet L C M van Riel; Andrea W M Evers
Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses.
E B M Kroft; M C W Creemers; F H J van den Hoogen; Jan B M Boezeman; Elke M G J de Jong
Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of M C W Creemers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Laura T C van Hulst; M C W Creemers; Jaap Fransen; Linda C Li; Richard Grol; Marlies E J L Hulscher; Piet L C M van Riel
How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led intervention.
Rheumatology (Oxford, England) 2010;49(4):741-8.
2010: Sabine J M de Brouwer; Floris W Kraaimaat; Fred C G J Sweep; M C W Creemers; Timothy R D J Radstake; Antoinette I M van Laarhoven; Piet L C M van Riel; Andrea W M Evers
Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses.
Arthritis research & therapy 2010;12(3):R89.
2009: E B M Kroft; M C W Creemers; F H J van den Hoogen; Jan B M Boezeman; Elke M G J de Jong
Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
The British journal of dermatology 2009;160(5):1075-82.
2008: Frank A D T G Wagener; Erik J M Toonen; Lonneke Wigman; Jaap Fransen; M C W Creemers; Timothy R D J Radstake; Marieke Coenen; Pilar Barrera; Piet L C M van Riel; Frans G M Russel
HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis.
Arthritis and rheumatism 2008;58(11):3388-93.
2008: Erik J M Toonen; Marieke Coenen; W Kievit; Jaap Fransen; A M M Eijsbouts; Hans Scheffer; Timothy Radstake; M C W Creemers; D-J R A M de Rooij; P L C M van Riel; B Franke; Pilar Barrera
The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(8):1174-7.
2007: Annelies van Ede; Alfons A den Broeder; Michiel Wagenaar; P L C M van Riel; M C W Creemers
Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis.
The Journal of rheumatology 2007;34(7):1590-2.
2007: Alfons A den Broeder; M C W Creemers; Jaap Fransen; Eefje de Jong; Dirk-Jan Ram de Rooij; Ate Wymenga; Maarten C de Waal Malefijt; F H J van den Hoogen
Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study.
The Journal of rheumatology 2007;34(4):689-95.
2007: Marcel Flendrie; M C W Creemers; P L C M van Riel
Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
Rheumatology (Oxford, England) 2007;46(1):146-9.
2005: Marcel Flendrie; M C W Creemers; Paco M J Welsing; P L C M van Riel
The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
Rheumatology (Oxford, England) 2005;44(4):472-8.
2005: Marcel Flendrie; W H P M Vissers; M C W Creemers; Elke M G J de Jong; P C M van de Kerkhof; P L C M van Riel
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.
Arthritis research & therapy 2005;7(3):R666-76.
2005: M C W Creemers; M J A M Franssen; M A van't Hof; F W J Gribnau; L B A Van De Putte; P L C M van Riel
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system.
Annals of the rheumatic diseases 2005;64(1):127-9.
2004: Jaap Fransen; M C W Creemers; P L C M van Riel
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria.
Rheumatology (Oxford, England) 2004;43(10):1252-5.
2004: Jaap Fransen; Jos W R Twisk; M C W Creemers; P L C M van Riel
Design and analysis of a randomized controlled trial testing the effects of clinical decision support on the management of rheumatoid arthritis.
Arthritis and rheumatism 2004;51(1):124-7.
2003: Marcel Flendrie; M C W Creemers; Paco M J Welsing; Alfons A den Broeder; P L C M van Riel
Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62 Suppl 2():ii30-3.
2002: M C W Creemers
Ankylosing spondylitis: what do we really know about the onset and progression of this disease?
The Journal of rheumatology 2002;29(6):1121-3.
2002: Alfons A den Broeder; M C W Creemers; Anke M van Gestel; P L C M van Riel
Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-alpha.
Rheumatology (Oxford, England) 2002;41(6):638-42.